BioCentury
ARTICLE | Distillery Therapeutics

Inhibiting NOX2 or FOXC1 to treat AML and CML

April 15, 2019 7:25 PM UTC

INDICATION: Acute myelogenous leukemia (AML); chronic myelogenous leukemia (CML)...